Changrayil Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 1.00 M
as on 19-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.85 M
as on 19-12-2024
- Satisfied Charges ₹ 5.00 M
as on 19-12-2024
- Revenue -63.31%
(FY 2021)
- Profit -136.45%
(FY 2021)
- Ebitda -300.98%
(FY 2021)
- Net Worth -408.96%
(FY 2021)
- Total Assets 13.71%
(FY 2021)
About Changrayil Meditech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.85 M. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sankarankutty Satish, Krishnaraj Warrier, and Rajan Warrier serve as directors at the Company.
- CIN/LLPIN
U24232KL2016PTC039971
- Company No.
039971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Changrayil Meditech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajan Warrier  | Managing Director | 27-Jan-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sankarankutty Satish | Director | 27-Jan-2016 | Current |
| Krishnaraj Warrier | Director | 27-Jan-2016 | Current |
Financial Performance of Changrayil Meditech.
Changrayil Meditech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 63.31% decrease. The company also saw a substantial fall in profitability, with a 136.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 408.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Changrayil Meditech?
In 2021, Changrayil Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cath Medical Devices Private LimitedActive 15 years 10 months
Sankarankutty Satish and Krishnaraj Warrier are mutual person
- Sai & Kaaizeen Prosthetic Solutions Private LimitedActive 8 years 4 months
Sankarankutty Satish is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 May 2022 | ₹0.45 M | Open |
Others Creation Date: 27 Jul 2020 | ₹0.90 M | Open |
Others Creation Date: 17 Jun 2016 | ₹4.50 M | Open |
How Many Employees Work at Changrayil Meditech?
Unlock and access historical data on people associated with Changrayil Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Changrayil Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Changrayil Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
